These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Zarow C; Lyness SA; Mortimer JA; Chui HC Arch Neurol; 2003 Mar; 60(3):337-41. PubMed ID: 12633144 [TBL] [Abstract][Full Text] [Related]
6. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067 [TBL] [Abstract][Full Text] [Related]
7. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease. Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834 [TBL] [Abstract][Full Text] [Related]
8. Patterns of cognitive performance in Subcortical Ischemic Vascular Disease (SIVD). Scherr M; Krenn Y; Sorg C; Manoliu A; Trinka E; Förstl H; Staffen W; Bergmann HJ; Kirschner M; McCoy M J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):150-4. PubMed ID: 24276850 [TBL] [Abstract][Full Text] [Related]
9. [Vascular risk factors and cognitive impairment of patients with magnetic resonance imaging-defined subcortical ischemic depression]. Long Y; Yang TT; Sun ZW Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(5):307-11. PubMed ID: 22490832 [TBL] [Abstract][Full Text] [Related]
10. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. Mufson EJ; Ma SY; Cochran EJ; Bennett DA; Beckett LA; Jaffar S; Saragovi HU; Kordower JH J Comp Neurol; 2000 Nov; 427(1):19-30. PubMed ID: 11042589 [TBL] [Abstract][Full Text] [Related]
11. Forgetting in dementia with and without subcortical lacunes. Kramer JH; Mungas D; Reed BR; Schuff N; Weiner MW; Miller BL; Chui HC Clin Neuropsychol; 2004 Feb; 18(1):32-40. PubMed ID: 15595356 [TBL] [Abstract][Full Text] [Related]
12. Comparison of neuropsychiatric symptoms and diffusion tensor imaging correlates among patients with subcortical ischemic vascular disease and Alzheimer's disease. Tu MC; Huang WH; Hsu YH; Lo CP; Deng JF; Huang CF BMC Neurol; 2017 Jul; 17(1):144. PubMed ID: 28754095 [TBL] [Abstract][Full Text] [Related]
13. A neuropsychological profile and its correlation with neuroimaging markers in patients with subcortical ischaemic vascular dementia. Tian R; Zhang Y; Liu F; Xue X; Zhang Y; Tian Z; Fang T; Fan R; Li Y; Zhang N Int J Geriatr Psychiatry; 2023 Mar; 38(3):e5900. PubMed ID: 36862560 [TBL] [Abstract][Full Text] [Related]
14. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Jagust WJ; Chui HC; Kramer JH; Reed BR; Miller BL; Yaffe K; Weiner MW Neurology; 2003 Aug; 61(3):358-64. PubMed ID: 12913198 [TBL] [Abstract][Full Text] [Related]
15. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Mesulam M; Shaw P; Mash D; Weintraub S Ann Neurol; 2004 Jun; 55(6):815-28. PubMed ID: 15174015 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of diffusion tensor imaging in differentiating early-stage subcortical ischemic vascular disease, Alzheimer's disease and normal ageing. Tu MC; Lo CP; Huang CF; Hsu YH; Huang WH; Deng JF; Lee YC PLoS One; 2017; 12(4):e0175143. PubMed ID: 28388630 [TBL] [Abstract][Full Text] [Related]
17. Do Alzheimer's disease (AD) and subcortical ischemic vascular dementia (SIVD) progress differently? Hong YJ; Yoon B; Shim YS; Han IW; Han SH; Park KH; Choi SH; Ku BD; Yang DW Arch Gerontol Geriatr; 2014; 58(3):415-9. PubMed ID: 24332770 [TBL] [Abstract][Full Text] [Related]
18. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease. Counts SE; Che S; Ginsberg SD; Mufson EJ J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006 [TBL] [Abstract][Full Text] [Related]
19. Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders. Alexandris AS; Walker L; Liu AKL; McAleese KE; Johnson M; Pearce RKB; Gentleman SM; Attems J Neuropathol Appl Neurobiol; 2020 Apr; 46(3):264-278. PubMed ID: 31454423 [TBL] [Abstract][Full Text] [Related]
20. Loss of cholinergic pathways in vascular dementia of the Binswanger type. Tomimoto H; Ohtani R; Shibata M; Nakamura N; Ihara M Dement Geriatr Cogn Disord; 2005; 19(5-6):282-8. PubMed ID: 15785029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]